Key points are not available for this paper at this time.
sponsorship: Supported by the Belgian Directorate-General for Development Cooperation and Humanitarian Aid (grant number, 914010), the European and Developing Countries Clinical Trials Partnership EDCTP3 (grant numbers, 101195465 and 101195146), the Research Foundation-Flanders (grant numbers, G096222N, to Drs. Liesenborghs and Muyembe-Tamfum, and 12B1M24N, to Dr. Van Dijck), the African Coalition for Epidemic Research, Response, and Training network (which is part of the EDCTP2 Program, supported by the European Union under grant agreement RIA2016E-1612), and the Japan Agency for Medical Research and Development (grant numbers, JP24fk0108637 and JP24fk0108660) and in part by the National Cancer Institute, National Institutes of Health (contract number, 75N91019D00024), and the Canadian Institutes of Health Research and International Development Research Centre (grant number, MRR-184813). (Belgian Directorate-General for Development Cooperation and Humanitarian Aid|914010, European and Developing Countries Clinical Trials Partnership EDCTP3|101195465, European and Developing Countries Clinical Trials Partnership EDCTP3|101195146, Research Foundation-Flanders|G096222N, Research Foundation-Flanders|12B1M24N, African Coalition for Epidemic Research, Response, and Training network (EDCTP2 Program - European Union)|RIA2016E-1612, Japan Agency for Medical Research and Development|JP24fk0108637, Japan Agency for Medical Research and Development|JP24fk0108660, National Cancer Institute, National Institutes of Health|75N91019D00024, Canadian Institutes of Health Research and International Development Research Centre|MRR-184813)
Vakaniaki et al. (Wed,) studied this question.